Homepage
Medication Guide
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
504
Thursday, December 18th, 2025, 11:44
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
503
Thursday, December 18th, 2025, 11:37
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
504
Thursday, December 18th, 2025, 11:21
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
502
Thursday, December 18th, 2025, 11:12
Adverse Reactions of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a commonly used fixed-dose combination preparation for type 2 diabetes mellitus. While effectively controlling blood glucose, patients ne...
504
Thursday, December 18th, 2025, 11:05
What are the Precautions for Using Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a combination antihyperglycemic medication that plays an important role in the treatment of type 2 diabetes mellitus. To ensure medicatio...
502
Thursday, December 18th, 2025, 11:03
Dosage and Administration, Recommended Dosage of Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a fixed-dose combination oral antihyperglycemic medication. It combines sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, with met...
503
Thursday, December 18th, 2025, 11:00
What are the Indications for Sitagliptin/Metformin Extended-Release Tablets (Janumet XR)?
Sitagliptin/Metformin Extended-Release Tablets (Janumet XR) is a novel fixed-dose combination antihyperglycemic medication. It integrates two hypoglycemic ingredients with distinct mechanisms of actio...
501
Thursday, December 18th, 2025, 10:52
Where to Purchase Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR)
Sitagliptin/Metformin Hydrochloride Extended-Release Tablets (Janumet XR) is an important medication for the treatment of type 2 diabetes mellitus. Patients pay close attention to issues such as the l...
501
Wednesday, December 17th, 2025, 16:34
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
504
Wednesday, December 17th, 2025, 16:32
18 / 200
1993 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved